Design and Characterization of Swietenia mahagoni Jacq. Mediated Silver Nanoparticles for Hyperglycemic and Hyperlipidemic Control

The present book “Design and Characterization of Swietenia mahagoni Jacq. Mediated Silver Nanoparticles for Hyperglycemic and Hyperlipidemic Control” is a comprehensive study that integrates the principles of green chemistry nanotechnology and pharmacology. The work represents an innovative approach to developing biogenic silver nanoparticles using the leaf extract of Swietenia mahagoni Jacq.—a medicinal plant long valued in traditional medicine for its antidiabetic antihyperlipidemic and antioxidant properties. The phytochemicals present in S. mahagoni such as flavonoids alkaloids tannins and phenolic compounds act as both reducing and stabilizing agents in the formation of nanoparticles thereby eliminating the need for harmful chemical reagents. Among the noble metals used in nanomedicine silver nanoparticles (AgNPs) have gained considerable attention due to their versatile biomedical applications including antimicrobial antioxidant antidiabetic and antihyperlipidemic properties. However the conventional methods of synthesizing silver nanoparticles often involve toxic reducing agents and high energy consumption which limit their biomedical suitability.The subsequent pharmacological assessments in experimental animal models provide critical insights into the therapeutic potential of these nanoparticles in controlling hyperglycemia and hyperlipidemia. The synthesis of Swietenia mahagoni-mediated silver nanoparticles exemplifies how interdisciplinary research can yield practical solutions that are not only effective but also environmentally responsible.